Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05081609
Title IL Believe: A Study of TransCon IL-2 beta/gamma Alone or in Combination With Pembrolizumab or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (IL Believe)
Acronym IL Believe
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ascendis Pharma Oncology Division A/S
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Ascendis Pharma Investigational Site RECRUITING Boston Massachusetts 02114 United States Details
Ascendis Pharma Investigational Site RECRUITING Huntersville North Carolina 28078 United States Details
Ascendis Pharma Investigational Site RECRUITING Canton Ohio 44718 United States Details
Ascendis Pharma Investigational Site RECRUITING Cincinnati Ohio 45219 United States Details
Ascendis Pharma Investigational Site RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Ascendis Pharma Investigational Site RECRUITING Nashville Tennessee 37203 United States Details
Ascendis Pharma Investigational Site RECRUITING Southport Queensland 4215 Australia Details
Ascendis Pharma Investigational Site RECRUITING Adelaide South Australia 5000 Australia Details
Ascendis Pharma Investigational Site RECRUITING Seoul Songpa-gu 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field